---
category: news
title: "Axoltis teaming with InSilicoTrials on MS candidate NX210c"
excerpt: "The companies will use InSilicoTrials' simulation platform to assess NX210c's effectiveness with MS, other neurodegenerative disorders."
publishedDateTime: 2023-07-31T12:53:00Z
originalUrl: "https://multiplesclerosisnewstoday.com/news-posts/2023/07/31/axoltis-teaming-with-insilicotrials-ms-candidate-nx210c/"
webUrl: "https://multiplesclerosisnewstoday.com/news-posts/2023/07/31/axoltis-teaming-with-insilicotrials-ms-candidate-nx210c/"
type: article
quality: 4
heat: -1
published: false

provider:
  name: Multiple Sclerosis News Today
  domain: multiplesclerosisnewstoday.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "InSilicoTrials, Axoltis partner to work on potential ALS therapy"
    excerpt: "Axoltis Pharma is joining InSilicoTrials to advance the development of NX210c, its lead candidate for neurodegenerative diseases like ALS."
    publishedDateTime: 2023-07-28T17:37:00Z
    webUrl: "https://alsnewstoday.com/news/potential-als-therapy-nx210c-be-tested-insilico-axoltis-teamup/"
    type: article
    provider:
      name: ALS News Today
      domain: alsnewstoday.com
    quality: 19

secured: "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;e/tkIIXmxDwpcJN+wdy6sA=="
---

